A detailed history of Wolverine Trading, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 81,300 shares of EW stock, worth $5.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
81,300
Previous 3,549 2190.79%
Holding current value
$5.32 Million
Previous $339,000 2115.04%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $65,431 - $86,195
902 Added 34.08%
3,549 $339,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $163,346 - $205,830
2,647 New
2,647 $201,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $440,466 - $563,900
-6,449 Reduced 40.7%
9,395 $701,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $1.31 Million - $1.7 Million
15,844 New
15,844 $1.33 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $1.06 Million - $1.34 Million
10,418 New
10,418 $1.22 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $1.88 Million - $2.31 Million
-17,646 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $1.82 Million - $2.17 Million
17,646 New
17,646 $2 Million
Q2 2021

Aug 06, 2021

SELL
$83.84 - $104.76 $777,196 - $971,125
-9,270 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $729,363 - $840,510
9,270 New
9,270 $768,000
Q2 2020

Aug 13, 2020

SELL
$57.54 - $76.95 $233,554 - $312,340
-4,059 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$52.41 - $81.0 $630,701 - $974,754
-12,034 Reduced 74.78%
4,059 $796,000
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $618,986 - $708,682
8,633 Added 115.72%
16,093 $3.74 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $290,023 - $355,426
4,712 Added 171.47%
7,460 $1.62 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $102,198 - $130,392
2,748 New
2,748 $383,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.